(179 days)
Not Found
No
The summary describes a physical medical device (tracheostomy tubes) with new features related to materials and design, and the performance studies focus on physical properties and biocompatibility. There is no mention of software, algorithms, or any technology related to AI or ML.
Yes
The device is a tracheostomy tube intended to provide tracheal access for airway management, which is a medical intervention aimed at treating a health condition or maintaining bodily function.
No
The device is a tracheostomy tube, which is used for providing tracheal access for airway management, not for diagnosing a condition.
No
The device description clearly states it is a physical tracheostomy tube with a cuff, indicating it is a hardware device.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "providing tracheal access for airway management." This is a direct intervention on the patient's airway, not a test performed on a sample taken from the body to diagnose a condition.
- Device Description: The device is a "single cannula tracheostomy tube." This is a physical device inserted into the trachea.
- Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in samples
- Providing information for diagnosis, monitoring, or screening
The device is a medical device used for airway management, which is a therapeutic and supportive function, not a diagnostic one.
N/A
Intended Use / Indications for Use
The Shiley™ Neonatal, Pediatric & Pediatric Long Tracheostomy Tubes with TaperGuard Cuff are intended for use in providing tracheal access for airway management.
Product codes (comma separated list FDA assigned to the subject device)
JOH
Device Description
The subject devices are single use; single cannula tracheostomy tubes that are intended to provide an artificial airway for airway management. The new features on the subject devices include a new plasticizer, the addition of the TaperGuard cuff, and additional sizes.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
tracheal
Indicated Patient Age Range
Neonatal & pediatric
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Product performance testing, including cuff air seal, cuff fluid seal, removal force, and cuff pressure mapping, were performed with the conclusion that the subject devices can be expected to perform at least as well as the predicate and can be considered substantially equivalent. Additionally, biocompatibility testing was performed per ISO 10993-1:2009 including the following: cytotoxicity, sensitization, irritation, acute systemic toxicity, subchronic toxicity implantation, chemical characterization, and risk assessment. The device met all biocompatibility requirements for its intended use.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5800 Tracheostomy tube and tube cuff.
(a)
Identification. A tracheostomy tube and tube cuff is a device intended to be placed into a surgical opening of the trachea to facilitate ventilation to the lungs. The cuff may be a separate or integral part of the tracheostomy tube and is, when inflated, intended to establish a seal between the tracheal wall and the tracheostomy tube. The cuff is used to prevent the patient's aspiration of substances, such as blood or vomit, or to provide a means for positive-pressure ventilation of the patient. This device is made of either stainless steel or plastic.(b)
Classification. Class II.
0
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 13, 2015
Covidien Ms. Kelsey Lee Regulatory Affairs Product Manager 6135 Gunbarrel Avenue Boulder, CO 80301
Re: K142298
Trade/Device Name: Shiley™ Neonatal, Pediatric & Pediatric Long Tracheostomy Tubes with TaperGuard Cuff Regulation Number: 21 CFR 868.5800 Regulation Name: Tracheostomy Tube & Tube Cuff Regulatory Class: II Product Code: JOH Dated: January 9, 2015 Received: January 14, 2015
Dear Ms. Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Ms. Lee
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Tejashri Purohit-Sheth, M.D.
Tejashri Purohit-Sheth, M.D. Clinical Deputy Director DAGRID/ODE/CDRH FOR
Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
2
Indications for Use
K142298 510(k) Number (if known):
Device Name: Shiley™ Neonatal, Pediatric & Pediatric Long Tracheostomy Tubes with TaperGuard Cuff
Indications for Use:
The Shiley™ Neonatal, Pediatric & Pediatric Long Tracheostomy Tubes with TaperGuard Cuff are intended for use in providing tracheal access for airway management.
Prescription Use __ (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED)
CONCURRENCE OF CDRH, OFFICE OF DEVICE EVALUATION (ODE)
3
510(k) SUMMARY
In accordance with the Food and Drug Administration Rule to implement provisions of the Safe Medical Devices Act of 1990 and in conformance with 21 CFR 807.92, this information serves as a 510(k) Summary for the use of the Shiley™ Neonatal, Pediatric Long Tracheostomy Tubes with TaperGuard Cuff.
| Submitted By: | Covidien
6135 Gunbarrel Avenue
Boulder, CO 80301 |
|-----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Date: | February 12, 2015 |
| Contact Person: | Danielle Mueller
Regulatory Affairs Manager
(303) 305-2603 |
| Proprietary Name: | Shiley™ Neonatal, Pediatric & Pediatric Long
Tracheostomy Tubes with TaperGuard Cuff |
| Common Name: | Tracheostomy Tube & Tube Cuff |
| Device Classification Regulation: | 21 CFR 868.5800 – Class II |
| Device Product Code & Panel: | JOH |
| Predicate Devices: | Shiley™ Cuffed Pediatric & Pediatric Long (K955680)
Shiley™ Neonatal, Pediatric & Pediatric Long
Tracheostomy Tubes Cuffless (K122531)
Smiths Medical Bivona Aire-Cuf Tracheostomy Tubes
(K982641) |
Device Description
The subject devices are single use; single cannula tracheostomy tubes that are intended to provide an artificial airway for airway management. The new features on the subject devices include a new plasticizer, the addition of the TaperGuard cuff, and additional sizes.
Indications for Use/Intended Use
The subject and predicate Shiley™ devices have identical indications and similar indications to the BIVONA Aire-Cuf device. The indications for use are as follows:
The Shiley™ Neonatal, Pediatric Long Tracheostomy Tubes with TaperGuard Cuff are intended for use in providing tracheal access for airway management.
4
Technological Characteristics Comparison
The subject device only differs from the predicate Shiley™ Neonatal, Pediatric Long Tracheostomy Tubes Cuffless (K122531) with the addition of the cuff. They have identical indications, basic design and sizes. The subject device has a similar cuff to the predicate Shiley Cuffed Tubes (K955680) and BIVONA Tubes (K083641). The difference between the cuff on the subject and predicate tubes is the overall shape, which is taper-shaped in the subject versus barrel shaped in the predicates.
| SUBJECT DEVICE | PREDICATE DEVICE | |||
|---|---|---|---|---|
| Shiley™ Cuffed | Shiley™ Cuffed [K955680] | Shiley™ Cuffless [K122531] | BIVONA Aire-Cuf [K083641] | |
| Indications | Intended for use in providing tracheal access for airway management. | Identical | Identical | Intended to provide direct airway access for a tracheotomized patient for up to 29 days. It may be reprocessed for a single-patient use up to 5 times for pediatric sizes. |
| Patient population | Neonatal & pediatric | Pediatric | Neonatal & pediatric | Neonatal & pediatric |
| Sterilization | EtO | EtO | EtO | EtO |
| Cuff shape | Taper | Barrel | N/A | Barrel |
| Use | Single patient use | Identical | Identical | Identical |
| Sizes | 2.5-4.5 Neonatal | |||
| 2.5-5.5 Pediatric | ||||
| 5.0-6.5 Pediatric long | 4.0-5.5 Pediatric | |||
| 5.0-6.5 Pediatric long | 2.5-4.5 Neonatal | |||
| 2.5-5.5 Pediatric | ||||
| 5.0-6.5 Pediatric long | 2.5-4.0 Neonatal | |||
| 2.5-5.5 Pediatric | ||||
| Materials | ||||
| Cannula | Medical grade PVC with a citrate-based non-phthalate plasticizer | Medical grade PVC with a DEHP plasticizer | Medical grade PVC with a citrate-based non-phthalate plasticizer | Silicone |
| Flange | Medical grade PVC with a citrate-based non-phthalate plasticizer | Medical grade PVC with a DEHP plasticizer | Medical grade PVC with a citrate-based non-phthalate plasticizer | Silicone |
| ISO 15mm connector | Acrylonitrile butadiene styrene (ABS) | Medical grade PVC | ABS | ABS |
| Cuff | Medical grade PVC with a citrate- | Medical grade PVC with a DEHP | N/A | PVC |
| based non- | ||||
| phthalate | ||||
| plasticizer | plasticizer | |||
| Inflation system | Medical grade PVC | |||
| with a citrate- | ||||
| based non- | ||||
| phthalate | ||||
| plasticizer & PVC | Medical grade PVC | |||
| with a citrate- | ||||
| based non- | ||||
| phthalate | ||||
| plasticizer & PVC | N/A | Silicone & ABS | ||
| Obturator | Medical grade | |||
| polypropylene | Medical grade | |||
| polypropylene | Medical grade | |||
| polypropylene | Medical grade | |||
| polypropylene | ||||
| Neck strap | Cotton | Cotton | Cotton | Cotton |
5
Substantial Equivalence - Non-Clinical Evidence
Product performance testing, including cuff air seal, cuff fluid seal, removal force, and cuff pressure mapping, were performed with the conclusion that the subject devices can be expected to perform at least as well as the predicate and can be considered substantially equivalent. Additionally, biocompatibility testing was performed per ISO 10993-1:2009 including the following: cytotoxicity, sensitization, irritation, acute systemic toxicity, subchronic toxicity implantation, chemical characterization, and risk assessment. The device met all biocompatibility requirements for its intended use.
Substantial Equivalence - Clinical Evidence
N/A - Clinical evidence was not necessary to show substantial equivalence.
Substantial Equivalence - Conclusions
No new questions of safety and effectiveness have been raised. From the evidence presented in the Premarket Notification, the subject devices can be considered substantially equivalent.